Tocilizumab-anoh

CELLTRION USA, Inc.🇺🇸 United States

FDA Page

Effective Date: Jan 23, 2026
Approval ID: 60381a7e-d7ae-4384-925d-c19c418d1663
Products: 4 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TOCILIZUMAB-ANOH safely and effectively. See full prescribing information for TOCILIZUMAB-ANOH. TOCILIZUMAB-ANOH injection, for intravenous or subcutaneous use Initial U.S. Approval: 2025 Tocilizumab-anoh is biosimilar to ACTEMRA (tocilizumab).

Quick Stats

Total Products4

Labelers1

Label Sections22

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.